Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is a piperidine-based compound with the molecular formula C23H32N2O4. It features a benzyl ester functional group and is widely utilized in pharmaceutical research as a precursor or intermediate for synthesizing biologically active compounds. Its unique structure and properties contribute to its value in the development of pharmaceuticals and bioactive substances.

405057-76-3

Post Buying Request

405057-76-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • BENZYL 4-((TERT-BUTOXYCARBONYL)(METHYL)AMINO)PIPERIDINE-1-CARBOXYLATE

    Cas No: 405057-76-3

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • benzyl 4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]piperidine-1-carboxylate

    Cas No: 405057-76-3

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

405057-76-3 Usage

Uses

Used in Pharmaceutical Research:
4-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is used as a precursor or intermediate for the synthesis of various biologically active compounds, playing a crucial role in the development of new pharmaceuticals.
Used in Neurological Disorders:
In the field of neurological disorders, 4-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is used as a potential drug candidate, contributing to the advancement of treatments for conditions affecting the nervous system.
Used in Pain Relief:
4-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is also used as a potential drug candidate for pain relief, aiming to provide therapeutic options for individuals suffering from various types of pain.
Used in Other Therapeutic Uses:
Beyond neurological disorders and pain relief, 4-(N-TERT-BUTOXYCARBONYL-N-METHYLAMINO)PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER is employed in the development of drug candidates for a range of other therapeutic applications, showcasing its versatility in pharmaceutical research and development.

Check Digit Verification of cas no

The CAS Registry Mumber 405057-76-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,0,5 and 7 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 405057-76:
(8*4)+(7*0)+(6*5)+(5*0)+(4*5)+(3*7)+(2*7)+(1*6)=123
123 % 10 = 3
So 405057-76-3 is a valid CAS Registry Number.

405057-76-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name benzyl 4-[methyl-[(2-methylpropan-2-yl)oxycarbonyl]amino]piperidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names Benzyl 4-((tert-butoxycarbonyl)(methyl)amino)piperidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:405057-76-3 SDS

405057-76-3Relevant articles and documents

BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS

-

Page/Page column 40-41, (2009/07/17)

The invention provides novel bis-pyridylpyridones which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, processes for their preparation, and their use in therapy and for the treatment of obesity and/or diabetes.

PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS

-

Page/Page column 58, (2008/06/13)

The invention relates to novel pyridine derivatives of formula 1 and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and their use as neurohormonal antagonists, especially as urotensin II inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 405057-76-3